123 related articles for article (PubMed ID: 12399161)
21. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.
Naisbitt DJ; Hough SJ; Gill HJ; Pirmohamed M; Kitteringham NR; Park BK
Br J Pharmacol; 1999 Mar; 126(6):1393-407. PubMed ID: 10217534
[TBL] [Abstract][Full Text] [Related]
22. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
[TBL] [Abstract][Full Text] [Related]
23. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).
Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804
[TBL] [Abstract][Full Text] [Related]
24. Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole.
Gruchalla RS; Pesenko RD; Do TT; Skiest DJ
J Allergy Clin Immunol; 1998 Mar; 101(3):371-8. PubMed ID: 9525454
[TBL] [Abstract][Full Text] [Related]
25. Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes.
Goldman JL; Koen YM; Rogers SA; Li K; Leeder JS; Hanzlik RP
Drug Metab Dispos; 2016 Oct; 44(10):1603-7. PubMed ID: 27457783
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.
Vyas PM; Roychowdhury S; Woster PM; Svensson CK
Biochem Pharmacol; 2005 Jul; 70(2):275-86. PubMed ID: 15894292
[TBL] [Abstract][Full Text] [Related]
27. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
29. An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs.
Cribb AE; Spielberg SP
Vet Res Commun; 1990; 14(3):241-52. PubMed ID: 2382408
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
[TBL] [Abstract][Full Text] [Related]
31. Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides.
Elzagallaai AA; Sultan EA; Bend JR; Abuzgaia AM; Loubani E; Rieder MJ
J Clin Pharmacol; 2020 Mar; 60(3):409-421. PubMed ID: 31709574
[TBL] [Abstract][Full Text] [Related]
32. Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites.
Choquet-Kastylevsky G; Santolaria N; Tedone R; Aujoulat M; Descotes J
Toxicol Lett; 2001 Mar; 119(3):183-92. PubMed ID: 11246171
[TBL] [Abstract][Full Text] [Related]
33. Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulphonamide hypersensitivity: a naturally occurring model of idiosyncratic drug toxicity.
Lavergne SN; Danhof RS; Volkman EM; Trepanier LA
Clin Exp Allergy; 2006 Jul; 36(7):907-15. PubMed ID: 16839406
[TBL] [Abstract][Full Text] [Related]
34. Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells.
Leeder JS; Nakhooda A; Spielberg SP; Dosch HM
Biochem Pharmacol; 1991 Feb; 41(4):575-83. PubMed ID: 1997006
[TBL] [Abstract][Full Text] [Related]
35. Haptenation of sulfonamide reactive metabolites to cellular proteins.
Manchanda T; Hess D; Dale L; Ferguson SG; Rieder MJ
Mol Pharmacol; 2002 Nov; 62(5):1011-26. PubMed ID: 12391263
[TBL] [Abstract][Full Text] [Related]
36. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.
Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640
[TBL] [Abstract][Full Text] [Related]
37. Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism.
Cribb AE; Nakamura H; Grant DM; Miller MA; Spielberg SP
Biochem Pharmacol; 1993 Mar; 45(6):1277-82. PubMed ID: 8466547
[TBL] [Abstract][Full Text] [Related]
38. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
[TBL] [Abstract][Full Text] [Related]
39. "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.
Lavergne SN; Wang H; Callan HE; Park BK; Naisbitt DJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):372-81. PubMed ID: 19666748
[TBL] [Abstract][Full Text] [Related]
40. Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.
Elsheikh A; Lavergne SN; Castrejon JL; Farrell J; Wang H; Sathish J; Pichler WJ; Park BK; Naisbitt DJ
J Immunol; 2010 Dec; 185(11):6448-60. PubMed ID: 20980635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
